Clinical support for low-cost tablets to treat coronavirus 23-Mar-2022 By Nicola Gordon-Seymour Chewable tablets or capsules formulated with dextrose or sorbitol and added bovine lactoferrin (bFL) offer a low cost and easy to produce preventative or clinical treatment for coronavirus strains, including COVID-19, according to a new study.